Suspension of trading
Oncternal Therapeutics, Inc. Share Price
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 01/25/01 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 01/25/01 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 15.59L 13.68L 12.74L 11.71L 21.96L 15Cr 22.34L 1.51Cr 59.15L 7.38Cr 58.51L 57.25L 26Cr | P/E 2022 |
-1.19x | P/E 2023 | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | -3.24Cr -2.84Cr -2.65Cr -2.43Cr -4.56Cr -309.33Cr -4.64Cr -31Cr -12Cr -153.41Cr -12Cr -12Cr -530.03Cr | EV / Sales 2022 |
-4.9x | EV / Sales 2023 | -2.95x |
| Free-Float |
90.77% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -24.11% |
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 92.6 |
| 10 years | 0.53 | | 211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 01/04/2017 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2023 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Hale
CHM | Chairman | 77 | 01/12/2018 |
Dan Kisner
BRD | Director/Board Member | 79 | 07/06/2019 |
Rosemary Mazanet
BRD | Director/Board Member | 70 | 27/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -92.96% | 15.59L | |
| +0.14% | -0.85% | -1.20% | +11.73% | 4.77TCr | |
| -2.24% | +1.92% | +385.05% | +630.47% | 4TCr | |
| +1.40% | +6.40% | +13.38% | +57.74% | 3.62TCr | |
| +13.94% | +19.15% | +21.98% | +8.18% | 3.56TCr | |
| -0.73% | +2.78% | +4.65% | +41.16% | 2.79TCr | |
| +0.40% | +1.06% | - | - | 1.67TCr | |
| -3.12% | +8.15% | +27.59% | +129.42% | 1.65TCr | |
| +2.39% | -3.63% | -0.35% | +10.34% | 1.32TCr | |
| +6.79% | +8.46% | -3.62% | -25.41% | 1.29TCr | |
| Average | -0.38% | -0.08% | +49.72% | +85.63% | 2.47TCr | |
| Weighted average by Cap. | +2.34% | +2.95% | +74.49% | +135.78% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 14.9L 13.08L 12.18L 11.2L 20.99L 14Cr 21.35L 1.44Cr 56.54L 7.06Cr 55.94L 54.73L 24Cr | 8L 7L 6L 6L 11.06L 7.5Cr 11.25L 76.11L 29.79L 3.72Cr 29.47L 28.83L 13Cr |
| Net income | -4.42Cr -3.88Cr -3.61Cr -3.32Cr -6.22Cr -421.98Cr -6.33Cr -43Cr -17Cr -209.28Cr -17Cr -16Cr -723.05Cr | -3.95Cr -3.46Cr -3.23Cr -2.97Cr -5.56Cr -377.17Cr -5.66Cr -38Cr -15Cr -187.05Cr -15Cr -15Cr -646.26Cr |
| Net Debt | -6.36Cr -5.58Cr -5.2Cr -4.78Cr -8.97Cr -607.96Cr -9.12Cr -62Cr -24Cr -301.51Cr -24Cr -23Cr -1.04TCr | -3.39Cr -2.98Cr -2.77Cr -2.55Cr -4.78Cr -324.22Cr -4.86Cr -33Cr -13Cr -160.79Cr -13Cr -12Cr -555.54Cr |
Employees
29
- Stock Market
- Stocks
- ONCT Stock
Select your edition
All financial news and data tailored to specific country editions
